Literature DB >> 17316096

Effects of sample storage conditions on glycated hemoglobin measurement: evaluation of five different high performance liquid chromatography methods.

Randie R Little1, Curt L Rohlfing, Alethea L Tennill, Shawn Connolly, Steve Hanson.   

Abstract

BACKGROUND: Glycated hemoglobin, reported as hemoglobin A1c (HbA1c), is widely used as a measure of long-term glycemic control in patients with diabetes. The accuracy of measurements depends in part on proper storage of the sample prior to analysis.
METHODS: Three whole blood (WB) samples at three HbA1c levels were collected and stored at -70 degrees C, -20 degrees C, 4 degrees C, room temperature (17-23 degrees C), and 37 degrees C. One aliquot from each temperature was analyzed by each method on days 1, 2, 3, 6, 7, 10, 14, 21, 28, and 57.
RESULTS: The Primus CLC (385 and 330) (Primus Corp., Kansas City, MO) showed stability of WB at -20 degrees C and 4 degrees C for 57 days, room temperature for 14 days, and 37 degrees C for 1 day. The Tosoh 2.2 Plus (Tosoh Bioscience, Inc., South San Francisco, CA) showed stability at -20 degrees C for 3 days, 4 degrees C for 14 days, room temperature for 3 days, and 37 degrees C for less than 24 h. With the Tosoh G7, results were acceptable at -20 degrees C for 10 days, 4 degrees C for 57 days, room temperature for 7 days, and 37 degrees C for less than 24 h. The Bio-Rad Variant (Bio-Rad Laboratories, Hercules, CA) showed stability at -20 degrees C for 6 days, 4 degrees C for 14 days, room temperature for 3 days, and 37 degrees C for less than 24 h. The Bio-Rad Variant II showed stability at -20 degrees C for 28 days, 4 degrees C for 57 days, room temperature for 7 days, and 37 degrees C for less than 24 h.
CONCLUSIONS: All methods either met or exceeded manufacturers' claims for stability. The CLC 385/330, Tosoh G7, and Bio-Rad Variant II high performance liquid chromatography methods showed better stability than the Tosoh 2.2 Plus and Bio-Rad Variant.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316096     DOI: 10.1089/dia.2006.0055

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  19 in total

1.  Ex vivo instability of glycated albumin: A role for autoxidative glycation.

Authors:  Joshua W Jeffs; Shadi Ferdosi; Hussein N Yassine; Chad R Borges
Journal:  Arch Biochem Biophys       Date:  2017-07-13       Impact factor: 4.013

2.  Diagnosing diabetes--time for a change?

Authors:  K Borch-Johnsen; S Colagiuri
Journal:  Diabetologia       Date:  2009-09-08       Impact factor: 10.122

3.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

4.  P3 Fraction: Effect on HbA1c Values by HPLC.

Authors:  Mrinal Gupta; Mohit Thalquotra; Pragna Rao
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 5.  Antepartum A1C, maternal diabetes outcomes, and selected offspring outcomes: an epidemiological review.

Authors:  Jodie Katon; Michelle A Williams; Gayle Reiber; Edith Miller
Journal:  Paediatr Perinat Epidemiol       Date:  2011-03-21       Impact factor: 3.980

6.  Hemoglobin A1c and postpartum abnormal glucose tolerance among women with gestational diabetes mellitus.

Authors:  Jodie Katon; Gayle Reiber; Michelle A Williams; David Yanez; Edith Miller
Journal:  Obstet Gynecol       Date:  2012-03       Impact factor: 7.661

7.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

8.  Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L).

Authors:  Evangelos N Liberopoulos; Matilda Florentin; Anastazia Kei; Elisavet Mountzouri; Aris Agouridis; Moses S Elisaf
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-07-01       Impact factor: 3.738

Review 9.  A1C versus glucose testing: a comparison.

Authors:  David B Sacks
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

10.  Hemoglobin a1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women.

Authors:  Jennifer K Pai; Leah E Cahill; Frank B Hu; Kathryn M Rexrode; Joann E Manson; Eric B Rimm
Journal:  J Am Heart Assoc       Date:  2013-03-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.